Faculty Information   
   日本語 >>
  1. TOP page
  2. >
  3. Clinical Medicine Seminars

Journal
Presentation
    (Last updated : 2022-10-18 16:10:42)
  Azuma Naoto
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article  Relapsing polychondritis coexisting with immune thrombocytopenic purpura: an unusual association. 2013/04
2. Original article  Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sjögren's syndrome. 2013/11
3. Original article  Relationship between YKL-40 and Pulmonary Arterial Hypertension in Systemic Sclerosis. 2018/05
4. Original article  Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. 2019/05 Link
5. Case report  Efficacy of using trimethoprim-sulfamethoxazole prophylaxis in an adult patient with autoimmune neutropenia. 2019/09
6. Original article  Evaluation of changes in oral health-related quality of life over time in patients with Sjögren's syndrome. 2021/05
7. Original article  Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis. 2022/01
8. Original article  Abatacept Ameliorates Both Glandular and Extraglandular Involvements in Patients With Sjögren's Syndrome Associated with Rheumatoid Arthritis: Findings from an Open-Label, Multicenter, 1-Year, Prospective Study: the ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren's Syndrome Endocrinopathy) and ROSE II trials. 2022/02
Display 5 items
Display all(8)
■ Presentation
1. Effect of abatacept on bone homeostasis and osteopontin in rheumatoid arthritis.  2013/06/15
2. Soluble interleukin-2 receptor levels and the CD4/CD8 ratio as predictors of the efficacy of abatacept in biologics-naïve rheumatoid arthritis patients.  2013/10/29
3. Immune-related Adverse events induced by cancer immunotherapies. Big data analysis of 13,051cases (immunocancer international registry).  2019/06/13
4. Phenotypic clusters of rheumatic/systemic immune-related adverse events induced by cancer immunotherapies (immunocancer international registry).  2019/06/13
5. Systemic Immune-inflammation index in rheumatoid arthritis patients:relation to disease activity.  2019/06/13
6. Circulating cell free DNA released from eosinophils is a practical biomarker in patients with eosinophilic granulomatosis with polyangiitis.  2019/11/11
7. Evaluation of changes in oral health-related quality of life over time in patients with Sjögren’syndrome.  2019/11/11
8. Relationship between YKL-40, VEGF, and IL-5 in borderline mPAP and pulmonary hypertension in systemic sclerosis.  2019/11/11
9. Increased levels of serum wisteria floribunda agglutininpositive Mac-2 binding protein in rheumatic diseases including SLE.  2021/06/02
10. Successful treatment of checkpoint inhibitor-induced arthritis with the IL-6 receptor inhibitor Sarilumab.  2021/08/28
11. Plasma cell-free DNA is a useful biomarker for tocilizumab therapy in rheumatoid arthritis.  2021/11/08
12. Neutrophil count reduction 1month after initiating sarilumab and baseline serum soluble gp130 levels can independently predict clinical remission within 3 month in rheumatoid arthritis patients.  2022/06/01
13. Sodium bicarbonate mouth rinse is a useful self-care method for dry mouth in patients with sjögren’syndrome.  2022/06/01
14. The baseline serum soluble TNF receptor level are associated with the response of rheumatoid arthritis
patients to JAKinibs.  2022/06/01
Display 5 items
Display all(14)

mail